Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway
Wenna Yu, Fuling Zeng, Yang Xiao, Liuyan Chen, Hengdong Qu, Jian Hong, Chen Qu, Guohua Cheng, Guohua Cheng
Topics & Concepts
PKM2GemcitabineCancer researchGene knockdownCell cultureMetastasisGene silencingChemistryCell cyclePharmacologyBiologyCellMedicinePyruvate kinaseCancerGlycolysisInternal medicineBiochemistryEnzymeGeneGeneticsCholangiocarcinoma and Gallbladder Cancer StudiesMicroRNA in disease regulationPeptidase Inhibition and Analysis